Canada markets close in 4 hours 1 minute

Baxter International Inc. (BAX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
42.65-0.04 (-0.09%)
As of 11:59AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close42.69
Open42.74
Bid42.72 x 800
Ask42.73 x 1000
Day's Range42.62 - 43.12
52 Week Range31.01 - 50.21
Volume544,498
Avg. Volume3,814,360
Market Cap21.724B
Beta (5Y Monthly)0.62
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.16 (2.72%)
Ex-Dividend DateFeb 29, 2024
1y Target EstN/A
  • Business Wire

    Baxter to Host Annual Meeting of Stockholders in Virtual Format

    DEERFIELD, Ill., March 27, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2024 Annual Meeting) in a virtual format on Tuesday, May 7, 2024 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the 2024 Annual Meeting. Online access to the 2024 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2024 Annual Meeting in person. The virtual format provides a convenien

  • Business Wire

    Baxter to Present at Raymond James 45th Annual Institutional Investors Conference

    DEERFIELD, Ill., February 29, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 45th Annual Institutional Investors Conference on Monday, March 4, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 4:00 p.m. Eastern Time.

  • GlobeNewswire

    Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

    Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDATORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, is pleased to announce an extension to its supply and distribution agreement (the “Amended Agreement”) with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (“Baxter”) (NYSE: BAX), or